| Exagamglogene autotemcel for severe sickle cell disease H Frangoul, F Locatelli, A Sharma, M Bhatia, M Mapara, L Molinari, D Wall, ... New England Journal of Medicine 390 (18), 1649-1662, 2024 | 371 | 2024 |
| Advances in the diagnosis and treatment of sickle cell disease AM Brandow, RI Liem Journal of hematology & oncology 15 (1), 20, 2022 | 260 | 2022 |
| Challenges of alloimmunization in patients with haemoglobinopathies ST Chou, RI Liem, AA Thompson British journal of haematology 159 (4), 394-404, 2012 | 223 | 2012 |
| American Society of Hematology 2019 guidelines for sickle cell disease: cardiopulmonary and kidney disease RI Liem, S Lanzkron, T D. Coates, L DeCastro, AA Desai, KI Ataga, ... Blood advances 3 (23), 3867-3897, 2019 | 196 | 2019 |
| Exagamglogene autotemcel for transfusion-dependent β-thalassemia F Locatelli, P Lang, D Wall, R Meisel, S Corbacioglu, AM Li, ... New England Journal of Medicine 390 (18), 1663-1676, 2024 | 182 | 2024 |
| Association of sickle cell trait with hemoglobin A1c in African Americans ME Lacy, GA Wellenius, AE Sumner, A Correa, MR Carnethon, RI Liem, ... Jama 317 (5), 507-515, 2017 | 178 | 2017 |
| Technology access and smartphone app preferences for medication adherence in adolescents and young adults with sickle cell disease SM Badawy, AA Thompson, RI Liem Pediatric Blood & Cancer 63 (5), 848-852, 2016 | 136 | 2016 |
| American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation J Kanter, RI Liem, F Bernaudin, J Bolaños-Meade, CD Fitzhugh, ... Blood Advances 5 (18), 3668-3689, 2021 | 134 | 2021 |
| Adherence to hydroxyurea, health-related quality of life domains, and patients’ perceptions of sickle cell disease and hydroxyurea: a cross-sectional study in adolescents and … SM Badawy, AA Thompson, JS Lai, FJ Penedo, K Rychlik, RI Liem Health and quality of life outcomes 15 (1), 136, 2017 | 123 | 2017 |
| Barriers to hydroxyurea adherence and health‐related quality of life in adolescents and young adults with sickle cell disease SM Badawy, AA Thompson, FJ Penedo, JS Lai, K Rychlik, RI Liem European journal of haematology 98 (6), 608-614, 2017 | 111 | 2017 |
| Health‐related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease SM Badawy, AA Thompson, JS Lai, FJ Penedo, K Rychlik, RI Liem Pediatric Blood & Cancer 64 (6), e26369, 2017 | 103 | 2017 |
| Alloimmunization in sickle cell anemia in the era of extended red cell typing C O'Suoji, RI Liem, AK Mack, P Kingsberry, G Ramsey, AA Thompson Pediatric blood & cancer 60 (9), 1487-1491, 2013 | 97 | 2013 |
| A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy SM Badawy, U Beg, RI Liem, S Chaudhury, AA Thompson Blood advances 5 (2), 570-583, 2021 | 82 | 2021 |
| Health‐related quality of life in children with sickle cell anemia: impact of blood transfusion therapy LM Beverung, JJ Strouse, ML Hulbert, K Neville, RI Liem, B Inusa, B Fuh, ... American journal of hematology 90 (2), 139-143, 2015 | 81 | 2015 |
| Tricuspid regurgitant jet velocity is associated with hemolysis in children and young adults with sickle cell disease evaluated for pulmonary hypertension RI Liem, LT Young, AA Thompson Haematologica 92 (11), 1549-1552, 2007 | 79 | 2007 |
| Transition to adulthood and adult health care for patients with sickle cell disease or cystic fibrosis: current practices and research priorities S Lanzkron, GS Sawicki, KL Hassell, MW Konstan, RI Liem, SA McColley Journal of clinical and translational science 2 (5), 334-342, 2018 | 74 | 2018 |
| A multicenter randomized controlled trial of intravenous magnesium for sickle cell pain crisis in children DC Brousseau, JP Scott, O Badaki-Makun, DS Darbari, CE Chumpitazi, ... Blood, The Journal of the American Society of Hematology 126 (14), 1651-1657, 2015 | 74 | 2015 |
| Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome RI Liem, MR O'Gorman, DL Brown American journal of hematology 76 (1), 19-25, 2004 | 73 | 2004 |
| Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial AT Taher, MD Cappellini, A Kattamis, E Voskaridou, S Perrotta, AG Piga, ... The Lancet Haematology 9 (10), e733-e744, 2022 | 64 | 2022 |
| Healthcare utilization and hydroxyurea adherence in youth with sickle cell disease SM Badawy, AA Thompson, JL Holl, FJ Penedo, RI Liem Pediatric Hematology and Oncology 35 (5-6), 297-308, 2018 | 61 | 2018 |
